Trevena shares dropped 33.7% to $0.23 with a session volume of 23.65 million. Notably, TRV045 did not cause S1P1R desensitization or protein reduction, unlike fingolimod.
Jazz Pharmaceuticals announced Phase 2b trial results for suvecaltamide (JZP385) in essential tremor patients, revealing no significant improvements over placebo.
Plug Power achieves certification for its 1 MW stationary system, marking a milestone for green hydrogen expansion amid strategic business priorities and equipment sales focus.
Darden Restaurants reported Q4 results, and increased its dividend. The company also expects same-restaurant sales growth of 1.0% to 2.0% and new restaurant openings of 45 to 50.
Gilead Sciences announced its Phase 3 PURPOSE 1 trial results showing 100% efficacy of twice-yearly injectable lenacapavir in preventing HIV-1 in cisgender women. The trial met key efficacy endpoints, demonstrating superiority over daily Truvada and background HIV incidence.
PayPal appoints Srini Venkatesan of Walmart as new CTO, effective June 24. He will oversee technology development and implementation across the ecosystem.
Commercial Metals reported third-quarter results with net sales of $2.078 billion. Europe Steel Group saw improved performance. Available liquidity at $1.5 billion. Quarterly dividend of $0.18 announced. Expecting consistent results in Q4.